Plus, updates on buprenorphine, diclofenac sodium, secukinumab and other rheumatology drug news, safety information
Search results for: cardiovascular disease
2014 ACR/ARHP Annual Meeting: Lupus Nephritis
Multi-targeted, aggressive drug therapies needed for complete response, remission of this lupus complication
Nurses’ Health Study Continues to Offer Valuable Patient Data
Nurses’ cohort of 38 years provides wealth of patient information, research for rheumatologists
Hydrocodone Bitartrate, Secukinumab, Varenicline Updates, Trials, Approvals
Plus, rheumatology drug news, safety updates
Sugary Soft Drinks Can Raise Risk of Rheumatoid Arthritis
Study finds consuming one or more sugar-sweetened sodas daily can increase women’s chance of developing seropositive RA by more than 60%
How Wars Have Shaped Rheumatology
Treating sick, injured soldiers has taught physicians lessons about fighting infections, cancer
Inflammatory Origin of Fever Is Key to Diagnosis
Fever in rheumatology patients may present evidence of an inflammatory process
Drugs Studied for Use in Rheumatoid Arthritis, Weight Loss
Plus, rheumatology drug news from EULAR 2014
EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis
Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA
What’s New in Inflammatory Arthritis?
Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair
- « Previous Page
- 1
- …
- 55
- 56
- 57
- 58
- 59
- …
- 64
- Next Page »